NEW BRUNSWICK, N.J., Dec. 15, 2010 /PRNewswire-FirstCall/ —
Johnson & Johnson (NYSE:
JNJ) today announced that Alex Gorsky, currently Worldwide
Chairman, Medical Devices & Diagnostics (MD&D) and Sheri
McCoy, currently Worldwide Chairman, Pharmaceuticals, have been
appointed Vice Chairmen of the Executive Committee and join William
C. Weldon, Chairman of the Board and Chief Executive Officer, in an
expanded Office of the Chairman. Both appointments are
effective January 3, 2011.
“Alex and Sheri are proven leaders in driving high performance
and developing talent across multiple business segments.
These appointments will ensure we are well-positioned for
sustainable growth into the future,” said William C. Weldon,
Johnson & Johnson Chairman and Chief Executive Officer.
“The changes are an appropriate step in furthering our
long-term succession plans, and assuring talented, experienced
leaders at all levels of the organization.”
Mr. Gorsky, 50, will assume expanded responsibilities that
include the Medical Device & Diagnostics Group, Global Supply
Chain, Government Affairs & Policy and the Johnson &
Johnson Development Corporation.
In 2009, Mr. Gorsky was appointed Worldwide Chairman, Medical
Devices & Diagnostics Group. In 2008, he joined Ethicon
as Company Group Chairman and Worldwide Franchise Chairman and in
2009 became a member of the Executive Committee after being named
Worldwide Chairman of MD&D. Until 2004, he was Company Group
Chairman for Johnson & Johnson’s pharmaceutical businesses in
EMEA. Earlier, he served as President of Janssen Pharmaceutica Inc.
in the United States after spending 15 years in various sales,
marketing and management roles. In 2004, Mr. Gorsky joined the
Novartis Pharmaceuticals Corporation and was head of the North
American pharmaceuticals business.
‘/>”/>
SOURCE
